19.06.2013
- Turning around drugmaker AstraZeneca will be a long haul, with a strategy of revamping research and boosting acquisitions set to take up to four years to pay off, its chief...
10.06.2013
- AstraZeneca is to buy U.S. respiratory drug specialist Pearl Therapeutics for up to $1.15 billion as Britain's second biggest drugmaker steps up a drive to rebuild its product...
30.05.2013
- A decade ago, Royal Dutch/Shell's boss was fighting to close the gap between the truth about his company's oil and gas reserves and the much larger figure in its accounts. He lost...
